Novo Nordisk MediaRoom http://press.novonordisk-us.com/ Novo Nordisk MediaRoom Novo Nordisk Testimony for Public Hearing on Draft Guidances Relating to the Development of Biosimilar Products http://press.novonordisk-us.com/index.php?s=43&item=329 Fri, 11 May 2012 11:00:00 -0400 http://press.novonordisk-us.com/index.php?s=43&item=329 Novo Nordisk Inc. Appoints Robert Clark as Vice President, Regulatory Affairs http://press.novonordisk-us.com/index.php?s=43&item=328 Tue, 08 May 2012 17:25:56 -0400 http://press.novonordisk-us.com/index.php?s=43&item=328 Company Announcement: Operating profit increased by 18% in the first quarter of 2012 http://press.novonordisk-us.com/index.php?s=43&item=327 Sales growth of 13% driven by Victoza®, NovoLog® and Levemir® Fri, 27 Apr 2012 06:40:26 -0400 http://press.novonordisk-us.com/index.php?s=43&item=327 Novo Nordisk plans 15 percent expansion of U.S. work force in 2012 http://press.novonordisk-us.com/index.php?s=43&item=326 Recruiting to focus on diabetes sales force, other field-based positions Fri, 27 Apr 2012 06:00:00 -0400 http://press.novonordisk-us.com/index.php?s=43&item=326 Novo Nordisk Honored as a Best Place to Work in New Jersey http://press.novonordisk-us.com/index.php?s=43&item=325 Pharmaceuticals leader ranks in top four for eighth year; second top employer recognition in 2012 Thu, 26 Apr 2012 09:00:00 -0400 http://press.novonordisk-us.com/index.php?s=43&item=325